CN100430045C - 一种柴胡滴丸及其制备方法 - Google Patents
一种柴胡滴丸及其制备方法 Download PDFInfo
- Publication number
- CN100430045C CN100430045C CNB2004100198269A CN200410019826A CN100430045C CN 100430045 C CN100430045 C CN 100430045C CN B2004100198269 A CNB2004100198269 A CN B2004100198269A CN 200410019826 A CN200410019826 A CN 200410019826A CN 100430045 C CN100430045 C CN 100430045C
- Authority
- CN
- China
- Prior art keywords
- radix bupleuri
- polyethylene glycol
- extractum
- water
- reflux
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000006187 pill Substances 0.000 title claims abstract description 101
- 238000000034 method Methods 0.000 title claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 102
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 100
- 239000003814 drug Substances 0.000 claims abstract description 49
- 239000000284 extract Substances 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims abstract description 7
- 238000010992 reflux Methods 0.000 claims description 88
- 239000007788 liquid Substances 0.000 claims description 72
- 239000000203 mixture Substances 0.000 claims description 69
- 229940057995 liquid paraffin Drugs 0.000 claims description 63
- 238000002360 preparation method Methods 0.000 claims description 45
- 229940079593 drug Drugs 0.000 claims description 38
- 229940093429 polyethylene glycol 6000 Drugs 0.000 claims description 38
- 238000012869 ethanol precipitation Methods 0.000 claims description 34
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 claims description 33
- 230000002262 irrigation Effects 0.000 claims description 28
- 238000003973 irrigation Methods 0.000 claims description 28
- 241000202726 Bupleurum Species 0.000 claims description 13
- 239000002671 adjuvant Substances 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 8
- 239000012567 medical material Substances 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 4
- 239000002202 Polyethylene glycol Substances 0.000 claims 10
- 229920001223 polyethylene glycol Polymers 0.000 claims 10
- 230000000144 pharmacologic effect Effects 0.000 abstract description 3
- 239000013049 sediment Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 16
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 102000030621 adenylate cyclase Human genes 0.000 description 7
- 108060000200 adenylate cyclase Proteins 0.000 description 7
- 238000010579 first pass effect Methods 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- 229960001138 acetylsalicylic acid Drugs 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000007958 sleep Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 239000001828 Gelatine Substances 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229960001340 histamine Drugs 0.000 description 3
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 3
- 101710095468 Cyclase Proteins 0.000 description 2
- OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 2
- 208000022461 Glomerular disease Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010033645 Pancreatitis Diseases 0.000 description 2
- 206010033647 Pancreatitis acute Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 241000218636 Thuja Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 201000003229 acute pancreatitis Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 231100000852 glomerular disease Toxicity 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- QLPRYZXNWYTFCI-UHFFFAOYSA-N saikosaponin D Natural products CC1OC(OC2CCC3(C)C(CCC4(C)C3C=CC56OCC7(CCC(C)(C)CC57)C(O)CC46C)C2(C)CO)C(O)C(O)C1OC8OC(CO)C(O)C(O)C8O QLPRYZXNWYTFCI-UHFFFAOYSA-N 0.000 description 2
- PQPVAGWUNWFCJE-UHFFFAOYSA-N saikosaponin a Natural products CC1OC(OC2CCC3(C)C(C2)C(C)(CO)CC4(C)C3C=CC56OCC7(CCC(C)(C)CC57)C(O)CC46C)C(O)C(OC8OC(CO)C(O)C(O)C8O)C1O PQPVAGWUNWFCJE-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 239000007962 solid dispersion Substances 0.000 description 2
- 210000005090 tracheal smooth muscle Anatomy 0.000 description 2
- 206010001580 Albuminuria Diseases 0.000 description 1
- 230000003844 B-cell-activation Effects 0.000 description 1
- 241000510654 Bupleurum chinense Species 0.000 description 1
- 241000213015 Bupleurum scorzonerifolium Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 1
- KYWSCMDFVARMPN-MSSMMRRTSA-N Saikosaponin A Chemical compound O([C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@]([C@H]3[C@]([C@@H]4[C@@]([C@@]5(C[C@H](O)[C@]67CO[C@]5([C@@H]6CC(C)(C)CC7)C=C4)C)(C)CC3)(C)CC2)(C)CO)O[C@@H]([C@@H]1O)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KYWSCMDFVARMPN-MSSMMRRTSA-N 0.000 description 1
- SXILFEBNQCRWAL-UHFFFAOYSA-N Saikosaponin-f Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(OC2C(C3C(C4C(C5(CC(O)C6(CO)CCC(C)(C)CC6C5=CC4)C)(C)CC3)(C)CC2)(C)C)OC1COC1C(O)C(O)C(O)C(CO)O1 SXILFEBNQCRWAL-UHFFFAOYSA-N 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229910052956 cinnabar Inorganic materials 0.000 description 1
- OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 210000002443 helper t lymphocyte Anatomy 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000037111 immune power Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- -1 lipid peroxide Chemical class 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000036963 noncompetitive effect Effects 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000036385 rapid eye movement (rem) sleep Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000002992 thymic effect Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000009284 tracheal contraction Effects 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
组别 | 剂量(g/kg) | 扭体次数(次/20min) |
对照组 | - | 27.6±21.6 |
柴胡滴丸 | 4.0 | 10.8±7.8* |
柴胡口服液 | 4.0 | 12.3±10.2* |
阿斯匹林 | 0.2 | 5.0±8.1* |
Claims (11)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100198269A CN100430045C (zh) | 2004-06-30 | 2004-06-30 | 一种柴胡滴丸及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100198269A CN100430045C (zh) | 2004-06-30 | 2004-06-30 | 一种柴胡滴丸及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1714811A CN1714811A (zh) | 2006-01-04 |
CN100430045C true CN100430045C (zh) | 2008-11-05 |
Family
ID=35821170
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100198269A Active CN100430045C (zh) | 2004-06-30 | 2004-06-30 | 一种柴胡滴丸及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100430045C (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101015575B (zh) * | 2006-02-08 | 2011-10-05 | 天津天士力制药股份有限公司 | 一种柴胡滴丸的制备方法 |
CN101810654B (zh) * | 2009-02-24 | 2015-12-16 | 上海医药工业研究院 | 醋制柴胡溶剂提取物在制备降胆固醇药物中的应用 |
CN103364496B (zh) * | 2012-04-09 | 2016-07-06 | 天士力制药集团股份有限公司 | 同时测定柴胡浸膏中四种柴胡皂苷含量的方法 |
CN102631386B (zh) * | 2012-05-10 | 2013-09-18 | 四川德培源中药科技开发有限公司 | 柴胡解热镇痛制剂及其制备工艺 |
CN104840496B (zh) * | 2014-02-17 | 2019-03-22 | 天士力医药集团股份有限公司 | 一种柴胡滴丸及其制备方法 |
CN109745348A (zh) * | 2019-03-04 | 2019-05-14 | 河南福森药业有限公司 | 一种柴胡配方颗粒的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1436554A (zh) * | 2002-02-08 | 2003-08-20 | 上海华拓医药科技发展有限公司 | 柴黄滴丸 |
-
2004
- 2004-06-30 CN CNB2004100198269A patent/CN100430045C/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1436554A (zh) * | 2002-02-08 | 2003-08-20 | 上海华拓医药科技发展有限公司 | 柴黄滴丸 |
Non-Patent Citations (4)
Title |
---|
柴胡滴丸治疗病毒性上呼吸道感染103例. 左文革,柯海红.中医杂志,第44卷第4期. 2003 |
柴胡滴丸治疗病毒性上呼吸道感染103例. 左文革,柯海红.中医杂志,第44卷第4期. 2003 * |
聚乙二醇在剂型优化中的应用. 周文孝.中国药学杂志,第30卷第12期. 1995 |
聚乙二醇在剂型优化中的应用. 周文孝.中国药学杂志,第30卷第12期. 1995 * |
Also Published As
Publication number | Publication date |
---|---|
CN1714811A (zh) | 2006-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102225152B (zh) | 麦味地黄口服制剂的制备方法 | |
CN102068682A (zh) | 一种治疗消化系统疾病的中药组合物及其制备方法 | |
CN1840166A (zh) | 温胆汤现代中药口服制剂及其生产方法 | |
CN101757328B (zh) | 一种治疗感冒的感冒滴丸及其制备方法 | |
CN100430045C (zh) | 一种柴胡滴丸及其制备方法 | |
CN1748748A (zh) | 孕妇金花制剂及新的制备方法 | |
CN105456818A (zh) | 一种含有艾叶的治疗失眠的中药组合物及其制备方法 | |
CN115487239A (zh) | 一种治疗失眠伴焦虑抑郁的药物组合物及其制备方法 | |
CN100479837C (zh) | 治疗缺血性脑血管疾病的药物及其制造方法 | |
CN103520235A (zh) | 一种具有降脂功能的植物组合物及其制备方法与应用 | |
CN106236895A (zh) | 一种治疗咳嗽的中药及其制备方法 | |
CN113679779A (zh) | 一种具有抗抑郁功效的中药组合物及其制备方法和应用 | |
CN105434379A (zh) | 一种五花茶滴丸及其制备方法 | |
CN102949681B (zh) | 一种预防或治疗感冒的组合物及其制备方法 | |
CN105343660A (zh) | 一种治疗周围性眩晕的中药制剂及其制造方法 | |
CN101310739A (zh) | 一种桂枝茯苓组合物及其制备方法 | |
CN101214325B (zh) | 复方陈香胃药物的制备方法及其新用途 | |
CN109223739A (zh) | 一种组合物及其制备方法和应用 | |
CN104474040A (zh) | 一种防治偏头痛疾病的药物组合及其制备方法与应用 | |
CN103610843A (zh) | 一种具有解酒或护肝作用的白蔹提取物及其制备方法和应用 | |
CN103110743B (zh) | 一种治疗或预防神经衰弱的中药组合物及其制备方法 | |
CN102743477A (zh) | 一种治疗肝炎的中药制剂及其制备方法 | |
CN102973831B (zh) | 一种花芪制剂的制备方法 | |
CN108379362B (zh) | 一种钩吻减毒存效的配伍组合物及其制备方法 | |
CN1899428B (zh) | 治疗疼痛的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Tianjin Tasly Modern Chinese Medicine Resource Co., Ltd. Assignor: Tianjin Tianshili Pharmaceutical Co., Ltd. Contract record no.: 2011120000159 Denomination of invention: Radix bupleuri dripping pill and its preparing method Granted publication date: 20081105 License type: Exclusive License Open date: 20060104 Record date: 20110824 |
|
C56 | Change in the name or address of the patentee |
Owner name: TASLY PHARMACEUTICAL GROUP CO., LTD. Free format text: FORMER NAME: TIANJIN TASLY PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 300402, No. 1, Liaohe East Road, Beichen Science Park, Beichen District, Tianjin Patentee after: Tasly Pharmaceutical Group Co., Ltd. Address before: 300402, No. 1, Liaohe East Road, Beichen Science Park, Beichen District, Tianjin Patentee before: Tianjin Tianshili Pharmaceutical Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 300402, No. 1, Liaohe East Road, Beichen Science Park, Beichen District, Tianjin Patentee after: Tasly Pharmaceutical Group Limited by Share Ltd Address before: 300402, No. 1, Liaohe East Road, Beichen Science Park, Beichen District, Tianjin Patentee before: Tasly Pharmaceutical Group Co., Ltd. |